The recall was initiated on Dec. 23, 2024. The FDA rules it as a Class II recall, meaning it is classified as a “situation in which use of, or exposure to, a violative product may cause ...
However, on January 14, 2025, the FDA reclassified the recall as Class II, which it defines as "a situation in which use of or exposure to a violative product may cause temporary or medically ...